Recent Updates in the Role of Bispecifics in Multiple Myeloma: Highlights from ASH 2022 and Beyond

Shaji Kumar, MD reviews updates from ASH 2022 with a panel of experts, focusing on the use of bispecifics in the treatment of patients with multiple myeloma.